NCT05600933 Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment Status ENROLLING_BY_INVITATION Phase N/A
NCT05592639 VideoEndoscopic Radical Inguinal Lymphadenectomy for Penile Cancer Status ACTIVE_NOT_RECRUITING Phase NA
NCT05581004 A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors Status RECRUITING Phase PHASE1
NCT05578820 Safety, Tolerability and Pharmacokinetics Investigation of Stimotimagene Copolymerplasmid Status COMPLETED Phase PHASE1
NCT05561491 A Study of ONCOS-102 in Combination With Other Novel Immune-therapies in Advanced Treatment-resistant Melanoma Patients Status WITHDRAWN Phase PHASE2
NCT05551117 A Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid Tumors Status TERMINATED Phase PHASE2
NCT05539677 Biobank and Register of Patients With Agresive Tumors for Translational and Analytical Research Status RECRUITING Phase N/A
NCT05539118 Interferon-α1b Combined With Toripalimab and Anlotinib Hydrochloride in Advanced Unresectable Melanoma Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT05538130 A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT05527795 Predictive Clinical Features for Response to Adjuvant Immunotherapy in Stage II,III and IV Resected Melanoma Status RECRUITING Phase N/A
NCT05522660 Immunotherapy or Targeted Therapy With or Without Stereotactic Radiosurgery for Patients With Brain Metastases From Melanoma or Non-small Cell Lung Cancer Status RECRUITING Phase PHASE3
NCT05520294 Evaluating the Effects of Cannabis Use and Circulating Cannabinoids on Tumor Infiltrating Lymphocytes in Malignant Melanoma Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05512481 Camrelizumab Plus Apatinib and Temozolomide as Neoadjuvant in High Risk Acral Melanoma Status RECRUITING Phase PHASE2
NCT05500508 Oral AMXT 1501 Dicaprate in Combination With IV DFMO Status TERMINATED Phase PHASE1/PHASE2
NCT05496192 A Study of Nivolumab Intravenous (IV) to Subcutaneous (SC) Switch in Adjuvant Melanoma and Bladder Cancer Status WITHDRAWN Phase PHASE2
NCT05488483 A Study of Tumor Imaging With Multispectral Optoacoustic Tomography Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05483400 Open Label Phase 2 Basket Trial With Atezolizumab and Tiragolumab in Solid Tumors Status RECRUITING Phase PHASE2
NCT05478473 Clinical Study of Chidamide Combined With Toripalimab in the Treatment of Advanced Melanoma Status UNKNOWN Phase NA